Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.5%

6 terminated/withdrawn out of 57 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

4 trials in Phase 3/4

Results Transparency

2 of 24 completed trials have results

Key Signals

6 recruiting2 with results

Enrollment Performance

Analytics

N/A

33(76.7%)

Phase 2

3(7.0%)

Phase 1

2(4.7%)

Phase 4

2(4.7%)

Phase 3

2(4.7%)

Early Phase 1

1(2.3%)

43Total

N/A(33)

Phase 2(3)

Phase 1(2)

Phase 4(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (57)

Showing 20 of 57 trials

NCT06183437Phase 4Recruiting

The STOP-MED CTRCD Trial

Role: collaborator

NCT06908967Not ApplicableCompleted

A Performance Study Comparing the EyeMirage (Test Device) to Standard of Care (Reference Device) in Patients 18 to 65 Years of Age Undergoing Standard Eye Examinations Such as Visual Acuity, Visual Field, Color Vision, and Self-Paced Saccade for Various Conditions

Role: collaborator

NCT07171580Not ApplicableNot Yet Recruiting

Tailoring Post Discharge - Remote Education and Access for Cardiac Health

Role: lead

NCT07137299Not Yet Recruiting

POPQ Associated With Total Laparoscopic Hysterectomy

Role: collaborator

NCT05347238Recruiting

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

Role: collaborator

NCT04645927Not ApplicableCompleted

Clinical Trial to Study the Effects of Dietary Flax Beverage on Memory and Cognition